Literature DB >> 24610207

Ultrasound-guided percutaneous ethanol injection in papillary thyroid cancer metastatic lymph-nodes.

Guia Vannucchi1, Danila Covelli, Michela Perrino, Simone De Leo, Laura Fugazzola.   

Abstract

UNLABELLED: Post-operative neck nodal metastases are detected in 9-20 % of papillary thyroid cancer (PTC). Ultrasound-guided ethanol injection (UPEI) has been used with promising results in the treatment of PTC patients with limited number of lymph-node metastases. CLINICAL CASE: We report the imaging and biochemical documentation of UPEI results in four metastatic neck lymph-nodes of papillary thyroid-cancer. A significant reduction both in the diameter of the lymph-nodes and in the serum thyroglobulin levels were observed in all cases and have been reported in a step-by-step sequence.
CONCLUSION: the UPEI treatment is a simple and suitable tool for the treatment of PTC cervical lymph-node metastases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24610207     DOI: 10.1007/s12020-014-0215-0

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  10 in total

1.  Complete eradication of metastatic lymph node after percutaneous ethanol injection therapy: pathologic correlation.

Authors:  Yu-Mee Sohn; Soon Won Hong; Eun-Kyung Kim; Min Jung Kim; Hee Jung Moon; Soo Jin Kim; Eun Ju Son; Jin Young Kwak
Journal:  Thyroid       Date:  2009-03       Impact factor: 6.568

2.  Long-term outcome of ultrasound-guided percutaneous ethanol ablation of selected "recurrent" neck nodal metastases in 25 patients with TNM stages III or IVA papillary thyroid carcinoma previously treated by surgery and 131I therapy.

Authors:  Ian D Hay; Robert A Lee; Caroline Davidge-Pitts; Carl C Reading; J William Charboneau
Journal:  Surgery       Date:  2013-10-28       Impact factor: 3.982

3.  Management of recurrent/persistent papillary thyroid carcinoma: efficacy of the surgical option.

Authors:  Kathryn G Schuff
Journal:  J Clin Endocrinol Metab       Date:  2011-07       Impact factor: 5.958

4.  Efficacy of ultrasound-guided percutaneous ethanol injection treatment in patients with a limited number of metastatic cervical lymph nodes from papillary thyroid carcinoma.

Authors:  Arne Heilo; Eva Sigstad; Kristin Holgersen Fagerlid; Olav Inge Håskjold; Krystyna Kotanska Grøholt; Aasmund Berner; Trine Bjøro; Lars H Jørgensen
Journal:  J Clin Endocrinol Metab       Date:  2011-06-29       Impact factor: 5.958

5.  Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma.

Authors:  Jack M Monchik; Gianluca Donatini; Jason Iannuccilli; Damian E Dupuy
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

6.  The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation.

Authors:  Ji Hye Yim; Won Bae Kim; Eui Young Kim; Won Gu Kim; Tae Yong Kim; Jin-Sook Ryu; Gyungyub Gong; Suck Joon Hong; Young Kee Shong
Journal:  J Clin Endocrinol Metab       Date:  2011-04-20       Impact factor: 5.958

7.  Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma.

Authors:  B D Lewis; I D Hay; J W Charboneau; B McIver; C C Reading; J R Goellner
Journal:  AJR Am J Roentgenol       Date:  2002-03       Impact factor: 3.959

Review 8.  Thyroid cancer nodal metastases: biologic significance and therapeutic considerations.

Authors:  S K Grebe; I D Hay
Journal:  Surg Oncol Clin N Am       Date:  1996-01       Impact factor: 3.495

9.  Percutaneous ethanol injection therapy for locally recurrent papillary thyroid carcinoma.

Authors:  Chi Young Lim; Ji-Sup Yun; Jandee Lee; Kee-Hyun Nam; Woong Youn Chung; Cheong Soo Park
Journal:  Thyroid       Date:  2007-04       Impact factor: 6.568

10.  Controlling recurrent papillary thyroid carcinoma in the neck by ultrasonography-guided percutaneous ethanol injection.

Authors:  Byung Moon Kim; Min Jung Kim; Eun-Kyung Kim; Sung Il Park; Cheong Soo Park; Woong Youn Chung
Journal:  Eur Radiol       Date:  2007-11-27       Impact factor: 5.315

  10 in total
  6 in total

1.  Long-term outcomes of ethanol injection therapy for locally recurrent papillary thyroid cancer.

Authors:  Soo Young Kim; Seok-Mo Kim; Hojin Chang; Bup-Woo Kim; Chi Young Lim; Yong Sang Lee; Hang-Seok Chang; Cheong Soo Park
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-06-29       Impact factor: 2.503

2.  Adjuvant therapy with 131-iodine in patients with elevated serum thyroglobulin after reoperation due to papillary thyroid carcinoma lymph node metastases.

Authors:  Pedro W Rosario; Gabriela F Mourão; Thassio L Siman; Maria R Calsolari
Journal:  Endocrine       Date:  2014-09-10       Impact factor: 3.633

3.  External-beam radiotherapy for differentiated thyroid cancer locoregional control: A statement of the American Head and Neck Society.

Authors:  Ana P Kiess; Nishant Agrawal; James D Brierley; Umamaheswar Duvvuri; Robert L Ferris; Eric Genden; Richard J Wong; R Michael Tuttle; Nancy Y Lee; Gregory W Randolph
Journal:  Head Neck       Date:  2015-12-30       Impact factor: 3.147

4.  Chemical ablation therapy of recurrent mediastinal nodal metastasis in post-radiotherapy cancer patients.

Authors:  Xinglu Xu; Xiuling Li; Xin Ye; Gang Liu; Jun Wang; Zhaohui Peng; Tian Liang; Wei Yang; Xiaoguang Hao
Journal:  Med Oncol       Date:  2014-09-10       Impact factor: 3.064

Review 5.  Ethanol Ablation of the Thyroid Nodules: 2018 Consensus Statement by the Korean Society of Thyroid Radiology.

Authors:  Soo Yeon Hahn; Jung Hee Shin; Dong Gyu Na; Eun Joo Ha; Hye Shin Ahn; Hyun Kyung Lim; Jeong Hyun Lee; Jeong Seon Park; Ji Hoon Kim; Jin Yong Sung; Joon Hyung Lee; Jung Hwan Baek; Jung Hyun Yoon; Jung Suk Sim; Kwang Hwi Lee; Seon Mi Baek; So Lyung Jung; Yeo Koon Kim; Yoon Jung Choi
Journal:  Korean J Radiol       Date:  2019-04       Impact factor: 3.500

6.  Long-Term Efficacy of Ethanol Ablation as Treatment of Metastatic Lymph Nodes From Papillary Thyroid Carcinoma.

Authors:  Pål Stefan Frich; Eva Sigstad; Audun Elnæs Berstad; Kristin Holgersen Fagerlid; Trond Harder Paulsen; Trine Bjøro; Liv Ingrid Flinder
Journal:  J Clin Endocrinol Metab       Date:  2022-04-19       Impact factor: 6.134

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.